Instrumento Inactivo

Acciones Ambit Biosciences Corp

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Ambit Biosciences : Daiichi Sankyo and Ambit Announce Results of Tender Offer	11/11/14
Ambit Biosciences : Announces Expiration of Hart-Scott-Rodino Waiting Period	28/10/14
Ambit Biosciences : Announcement Regarding Submission of Tender Offer for Shares in Ambit Biosciences Corporation	14/10/14
Ambit Biosciences : Stockholders Encouraged to Contact Securities Law Firm about Takeover	01/10/14
Ambit Biosciences : Ryan & Maniskas, LLP : Announces Investigation of Ambit Biosciences Corporation	01/10/14

Directores	Puesto	Edad	Desde
Ken Takeshita CEO	Chief Executive Officer	-	-

Administradores	Puesto	Edad	Desde
Kenneth Joseph Keller BRD	Director/Board Member	61	10/11/14
Michael Martino CEO	Chief Executive Officer	68	16/11/11
Glenn Gormley BRD	Director/Board Member	-	10/11/14

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-4,24 %	86,85 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+2,76 %	40,16 mil M
BIOGEN INC.	-16,98 %	31,28 mil M
UCB	+57,86 %	25,27 mil M
BIOMARIN PHARMACEUTICAL INC.	-16,24 %	15,33 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12 %	11,96 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56 %	11,61 mil M
INCYTE CORPORATION	-17,10 %	11,69 mil M
SWEDISH ORPHAN BIOVITRUM AB	+6,89 %	8831,13 M